Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial
View through CrossRef
Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial.
Bipolar Disord 2012: 14: 64–70. © 2012 The Authors.
Journal compilation © 2012 John Wiley & Sons A/S.Background: Recent studies indicate that modulation of glutamate neurotransmission is associated with antidepressant response. Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD‐D); however, only 40–50% of patients have a full response. This pilot study investigated whether memantine, a low‐affinity N‐methyl‐D‐aspartate (NMDA) receptor antagonist approved for Alzheimer’s disease, can augment the effects of lamotrigine.Methods: BD‐D outpatients in a major depressive episode on a stable dose of lamotrigine (100 mg or more) were randomized to either memantine (starting dose of 5 mg increased up to 20 mg over four weeks, then 20 mg stable dose from four to eight weeks) or matching pill placebo for eight weeks. Patients were rated on the 17‐item Hamilton Depression Rating Scale (HDRS) and other behavioral measures weekly.Results: The eight‐week repeated‐measures mixed‐effect model for HDRS was not significant for memantine (n = 14) versus placebo (n = 15). Exploratory mixed‐effect analyses for the first four weeks, while the memantine dose was being titrated up every week, revealed a significant decrease in HDRS scores from baseline (p = 0.007).Conclusion: This proof‐of‐concept study failed to show a statistically significant benefit of memantine augmentation of lamotrigine for patients with BD‐D over eight weeks. However, memantine had an antidepressant effect early on in the treatment while its dose was being titrated up. Larger placebo‐controlled studies are needed to ascertain optimal timing and dosing for memantine augmentation of lamotrigine in BD‐D.
Title: Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial
Description:
Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S.
Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial.
Bipolar Disord 2012: 14: 64–70.
© 2012 The Authors.
Journal compilation © 2012 John Wiley & Sons A/S.
Background: Recent studies indicate that modulation of glutamate neurotransmission is associated with antidepressant response.
Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD‐D); however, only 40–50% of patients have a full response.
This pilot study investigated whether memantine, a low‐affinity N‐methyl‐D‐aspartate (NMDA) receptor antagonist approved for Alzheimer’s disease, can augment the effects of lamotrigine.
Methods: BD‐D outpatients in a major depressive episode on a stable dose of lamotrigine (100 mg or more) were randomized to either memantine (starting dose of 5 mg increased up to 20 mg over four weeks, then 20 mg stable dose from four to eight weeks) or matching pill placebo for eight weeks.
Patients were rated on the 17‐item Hamilton Depression Rating Scale (HDRS) and other behavioral measures weekly.
Results: The eight‐week repeated‐measures mixed‐effect model for HDRS was not significant for memantine (n = 14) versus placebo (n = 15).
Exploratory mixed‐effect analyses for the first four weeks, while the memantine dose was being titrated up every week, revealed a significant decrease in HDRS scores from baseline (p = 0.
007).
Conclusion: This proof‐of‐concept study failed to show a statistically significant benefit of memantine augmentation of lamotrigine for patients with BD‐D over eight weeks.
However, memantine had an antidepressant effect early on in the treatment while its dose was being titrated up.
Larger placebo‐controlled studies are needed to ascertain optimal timing and dosing for memantine augmentation of lamotrigine in BD‐D.
Related Results
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data (Preprint)
Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data (Preprint)
BACKGROUND
Depression in people with bipolar disorder is a major cause of long-term disability, possibly leading to early mortality and currently, limited s...
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Probably Induced by a Lamotrigine–Ginseng Drug Interaction
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Probably Induced by a Lamotrigine–Ginseng Drug Interaction
The likelihood of a drug reaction with lamotrigine is increased by dose escalation that is too rapid or drug interactions that increase the concentration of lamotrigine. There is a...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Correlation between postpartum depression and the number of births
Correlation between postpartum depression and the number of births
IntroductionPostpartum depression is a disorder that usually occurs six weeks after birth and can last for up to a year. If postpartum depression is not diagnosed and treated, ther...
STEVEN JOHNSONS SYNDROM ON LAMOTRIGINE
STEVEN JOHNSONS SYNDROM ON LAMOTRIGINE
Introduction: Lamotrigine is an anti-epileptic drug indicated for the treatment of bipolar disorder and recurrent depressive disorders. Its efficacy has been demonstrated. However,...
Neural Predictors of the Antidepressant Placebo Response
Neural Predictors of the Antidepressant Placebo Response
The antidepressant placebo response remains a barrier to the development of novel therapies for depression, despite decades of efforts to identify and methodologically address its ...
Absence of emergent suicidal ideation during treatment: A comparative, controlled, double‐blind analysis employing several distinct antidepressants
Absence of emergent suicidal ideation during treatment: A comparative, controlled, double‐blind analysis employing several distinct antidepressants
AbstractWe investigated 243 patients from a series of comparator and/or placebo‐controlled, double‐blind trials of several mechanistically distinct antidepressants. Data were analy...